Drug-labels.com Search Menu

Adempas: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.5 mg, 1 mg, 1.5 mg, 2 mg, 2.5 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Adempas

What is ADEMPAS used for?

ADEMPAS is used to treat pulmonary hypertension (high blood pressure in the lungs) in adults with the following conditions:

  • pulmonary arterial hypertension (PAH; WHO Group 1). It can be taken on its own or with other PAH medications as prescribed by your health care provider.
  • chronic thromboembolic pulmonary hypertension (CTEPH; WHO Group 4) when CTEPH cannot be resolved with an surgery, or if CTEPH is persistent or reoccurring after surgery.

How does ADEMPAS work?

ADEMPAS belongs to a class of medicines called soluble guanylate cyclase (sGC) stimulators. It works by stimulating an enzyme (sGC) in the blood vessels in the lungs, causing the blood vessels to relax and widen. This helps to lower the blood pressure in the lungs and improve the symptoms of pulmonary hypertension.

What are the ingredients in ADEMPAS?

Medicinal ingredient: Riociguat.

Non-medicinal ingredients: Cellulose microcrystalline, crospovidone, hydroxypropylcellulose, hypromellose 3cP, hypromellose 5cP, lactose monohydrate, magnesium stearate, sodium laurilsulphate, propylene glycol, and titanium dioxide.

In addition, the following tablet strengths also include other non-medicinal ingredients:

  • 1 mg and 1.5 mg: Ferric oxide yellow.
  • 2 mg and 2.5 mg: Ferric oxide red and ferric oxide yellow.

ADEMPAS comes in the following dosage forms:

Film-coated tablets: 0.5 mg (white), 1 mg (pale yellow), 1.5 mg (yellow-orange), 2 mg (pale orange), and 2.5 mg (red-orange) of riociguat.

Do not use ADEMPAS if:

  • you are allergic to riociguat or any of the other ingredients in ADEMPAS.
  • you are pregnant or planning to become pregnant.

  • you are breast-feeding or planning to breast-feed.
  • you are taking any of the following medicines:

    • sildenafil (e.g., VIAGRA or REVATIO), tadalafil (e.g., CIALIS or ADCIRCA), or vardenafil (e.g., LEVITRA and STAXYN) used to treat high blood pressure or erectile dysfunction.
    • nitrates or nitric oxide donors (e.g., amyl nitrite) used to treat high blood pressure of coronary artery disease (CAD; a heart condition involving the heart arteries that do not supply enough blood, oxygen and nutrients to the heart).
    • other sGC stimulators used to treat heart failure and PAH.

These are the common uses for each medicine. If you are unsure if you are taking these medicines, ask your healthcare professional.

  • you have high blood pressure in your lungs associated with scarring of the lungs from an unknown cause (idiopathic interstitial pneumonias).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ADEMPAS. Talk about any health conditions or problems you may have, including if you:

  • are at a higher risk of bleeding. This can include if you:

    • are receiving treatment or medicines used to prevent blood clots (anticoagulants).
    • have a history of coughing up blood from the lungs (hemoptysis).
    • have previously undergone a procedure called bronchial arterial embolization to stop coughing up blood from the lungs.
  • are receiving or plan to receive dialysis treatment.
  • have experienced a sudden drop in blood pressure when you stand from a sitting position or when you stand after lying down.
  • have heart or circulation problems.
  • have kidney problems.
  • have liver problems.
  • have low blood pressure.
  • have low fluid levels in your body (hypovolemia).
  • have lung or breathing problems.
  • have problems affecting your autonomic nervous system (ANS), which controls the automatic functions of the body.
  • have problems digesting certain sugars (e.g., lactose intolerance). ADEMPAS contains lactose, a milk sugar.
  • smoke cigarettes. You should not smock during your treatment with ADEMPAS. Tell your healthcare professional, if you plan to stop or start smoking cigarettes during treatment.

Other warnings you should know about:

Driving and using machines: ADEMPAS can cause dizziness. Before you drive or do tasks that require special attention, wait until you know how you respond to ADEMPAS.

Pregnancy: Do not take ADEMPAS if you are pregnant. If there is a chance you could become pregnant, use reliable forms of birth control while you are taking ADEMPAS. If you are unsure about your birth control options, talk to your healthcare professional. Tell your healthcare professional right away if you become pregnant while taking ADEMPAS.

Testing and check-ups: Your healthcare professional will monitor your health throughout your treatment. They may do this by performing certain tests before and regularly during your treatment. This can include specific tests to monitor your blood pressure and risk of bleeding. If you notice any unexpected or excessive bleeding, tell your healthcare professional.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

Serious Drug Interactions

Serious drug interactions with ADEMPAS include:

  • sildenafil (e.g., VIAGRA or REVATIO), tadalafil (e.g., CIALIS or ADCIRCA), or vardenafil (e.g., LEVITRA and STAXYN), medicines used to treat high blood pressure or erectile dysfunction. Before taking ADEMPAS, you must stop taking sildenafil for at least 24 hours and tadalafil for at least 48 hours.
  • nitrates or nitric oxide donors, medicines used to treat high blood pressure of coronary artery disease (CAD; a heart condition involving the heart arteries that do not supply enough blood, oxygen and nutrients to the heart).
  • other sGC stimulators, medicines used to treat heart failure and PAH.

Do not take ADEMPAS if you are taking any of these medicines. Ask your healthcare professional if you are unsure.

The following may interact with ADEMPAS:

  • antacids, medicines used to treat indigestion, heart burn, and upset stomach (e.g., aluminum hydroxide and magnesium hydroxide). Antacids should be taken at least 1 hour after ADEMPAS.
  • antiepileptics, medicines used to control seizures or fits (e.g., phenytoin, carbamazepine, and phenobarbitone).
  • antifungals, medicines used to treat fungal infections (e.g., ketoconazole, clotrimazole, miconazole, and itraconazole).
  • carvedilol, a medicine used to treat heart failure and high blood pressure.
  • cigarette smoking.
  • cyclosporine, a medicine used to prevent rejection of transplanted organs.
  • erlotinib (e.g., TARCEVA) or gefitinib (e.g., IRESSA), medicines used to treat cancer.
  • granisetron, a medicine used to treat nausea and vomiting.
  • medicines that can increase the pH of the upper gastrointestinal tract. Ask your healthcare professional if you are unsure.
  • medicines used to treat human immunodeficiency virus (HIV) infection (e.g., abacavir, atazanavir, cobicistat, darunavir, dolutegravir, efavirenz, elvitegravir, emtricitabine, indinavir, lamivudine, rilpivirine, ritonavir, saquinavir, and tenofovir).
  • niflumic acid, a medicine used to treat joints and muscular pain and inflammation.
  • quinidine, a medicine used to treat irregular heart rhythm and malaria.
  • St. John´s Wort, a herbal treatment for depression.
  • tyrosine kinase inhibitors, medicines used to prevent the rejection of transplanted organs (e.g., imatinib, sorafenib and sunitinib).

These are the common uses for each medicine. If you are unsure if you are taking these medicines, ask your healthcare professional

How to take ADEMPAS:

  • Always take this medicine exactly as your healthcare professional has told you. Check with your healthcare professional if you are not sure.
  • Treatment should only be initiated and monitored by a healthcare professional experienced in the treatment of CTEPH or PAH.
  • ADEMPAS can be taken with or without food.

Usual dose:

Your healthcare professional will determine the right dose for you. This may depend on your age, condition, health, and how you respond to ADEMPAS.

The usual starting dose is 1 mg three times a day (approximately every 6 to 8 hours apart) for 2 weeks. Your healthcare professional may increase your dose every 2 weeks to a maximum of 2.5 mg three times a day (total of 7.5 mg a day).

Overdose:

If you think you, or a person you are caring for, have taken too much ADEMPAS, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you miss a dose of ADEMPAS, skip the missed dose and take the next dose as scheduled. Do not double the dose to make up for the missed dose.

If you miss or forget to take ADEMPAS for 3 days or more, tell your healthcare professional. Your healthcare professional may need to adjust your dose.

What are possible side effects from using ADEMPAS?

These are not all the possible side effects you may have when taking ADEMPAS. If you experience any side effects not listed here, tell your healthcare professional.

Side effects of ADEMPAS may include:

  • abdominal pain or discomfort;
  • abdominal swelling or bloating;
  • constipation;
  • diarrhea;
  • dizziness;
  • headache;
  • indigestion
  • nasal congestion;
  • nausea;
  • vomiting.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
VERY COMMON
Bleeding events: nose bleeds, bleeding from the lungs, or coughing up blood.✓
Hypotension (low blood pressure): dizziness, fainting, light-headedness, blurred vision, nausea, vomiting, or fatigue (may occur when you go from lying or sitting to standing up).✓
Peripheral edema (swelling of the arms, hands, legs, or feet).✓
COMMON
Anemia (decreased number of red blood cells): fatigue, loss of energy, irregular heartbeats, pale complexion, shortness of breath, weakness✓
Dysphagia (difficulty swallowing): coughing or choking while eating or drinking, pain while swallowing, unable to swallow, drooling, hoarseness, regurgitating, heartburn, food or stomach acid backing up into the throat, or weight loss.✓
Gastritis (inflammation of the lining of the stomach): nausea, vomiting, feeling full in the upper abdomen after eating, or pain or burning in the upper abdomen that may get worse or better with eating.✓
Gastroenteritis (inflammation of the stomach and intestines): abdominal pain, diarrhea, nausea, or vomiting.✓
Gastroesophageal reflux disease (GERD) (stomach acid repeatedly flows back into the throat): heartburn after eating and might get worse at night or while lying down, regurgitating food or sour liquid, upper abdominal pain, chest✓

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
pain, difficulty swallowing, sensation of a lump in your throat, cough, or inflammation of the vocal cords.
Palpitations: heart is skipping beats, beating too fast, pounding, or fluttering rapidly.✓
Syncope (fainting): a temporary loss of consciousness due to a sudden drop in blood pressure.✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your healthcare professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store ADEMPAS at room temperature between 15°C and 30°C. Do not use after the expiry date stated on the label.

Keep out of reach and sight of children.

If you want more information about ADEMPAS:

  • Talk to your healthcare professional.
  • Find the full Product Monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s http://www.bayer.ca, or by calling Bayer Medical Information at 1-800-265-7382 or emailing canada.medinfo@bayer.com.

Bayer Inc.

2920 Matheson Boulevard East

Mississauga, Ontario

L4W 5R6

Last revised: October 13, 2022

© 2022, Bayer Inc.

® TM see www.bayer.ca/tm-mc

All other trademarks are the property of their respective owners.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02412764

Revision date stated in the text: October 13, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Adempas

Rx or OTC
Prescription (Rx)?
DIN 02412764, 02412772, 02412799, 02412802, 02412810
Schedule(s) PRESCRIPTION
Active ingredient(s) Riociguat
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. C Cardiovascular system drugs
    1. C02 Antihypertensives
      1. C02K Other antihypertensives
        1. C02KX Antihypertensives for pulmonary arterial hypertension
          1. C02KX05 Riociguat
Company BAYER INC
Current status Marketed
Current status date September 25, 2013
Strengths and forms
DIN Strength Dosage form(s) Current status
02412764 0.5 MG Tablet Marketed September 25, 2013
02412772 1 MG Tablet Marketed September 25, 2013
02412799 1.5 MG Tablet Marketed September 25, 2013
02412802 2 MG Tablet Marketed September 25, 2013
02412810 2.5 MG Tablet Marketed September 25, 2013

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 12, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.